How does USPH's PE Ratio compare to its peers?

USPH is expensive based on its Price-To-Earnings Ratio (94.4x) compared to the peer average (17.6x).

How does USPH's PE Ratio compare vs other companies in the US Healthcare Industry?

USPH is expensive based on its Price-To-Earnings Ratio (94.4x) compared to the US Healthcare industry average (23.3x).

What is USPH's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

USPH is expensive based on its Price-To-Earnings Ratio (94.4x) compared to the estimated Fair Price-To-Earnings Ratio (33.5x).

What is the Fair Price of USPH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

USPH ($88.18) is trading below our estimate of [[fair value]] ($187.03)

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

USPH Stock Overview

Operates outpatient physical therapy clinics. More details

USPH fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	4/6
Past Performance	0/6
Financial Health	4/6
Dividends	3/6

Rewards

Trading at 52.9% below our estimate of its fair value

Earnings are forecast to grow 30.76% per year

Analysts in good agreement that stock price will rise by 26.3%

Risk Analysis

Large one-off items impacting financial results

Profit margins (2.2%) are lower than last year (4.1%)

Dividend of 2% is not well covered by earnings

Significant insider selling over the past 3 months

My Notes

Capture your thoughts, links and company narrative

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

Analyst Price Target

Consensus Narrative from 6 Analysts

Injury Prevention Expansion And Acquisitions Will Drive Future Performance

Key Takeaways Strong growth in patient visits and injury prevention, along with strategic closures, aim to boost revenue and margins. Strategic acquisitions and reimbursement rate focus expected to significantly enhance revenue and profitability.

View narrative

US$111.33

20.8% undervalued

10.18%

Revenue growth p.a.

3 days ago

U.S. Physical Therapy, Inc. Competitors

National HealthCare

NYSEAM:NHC

US$1.6b

PACS Group

NYSE:PACS

US$2.1b

Ardent Health Partners

NYSE:ARDT

US$2.4b

Select Medical Holdings

NYSE:SEM

US$2.4b

Price History & Performance

Summary of share price highs, lows and changes for U.S. Physical Therapy
Historical stock prices
Current Share Price	US$88.18
52 Week High	US$113.63
52 Week Low	US$76.18
Beta	1.48
1 Month Change	-8.22%
3 Month Change	12.35%
1 Year Change	-4.97%
3 Year Change	-5.11%
5 Year Change	-23.63%
Change since IPO	3,548.82%

Capital Allocation Trends At U.S. Physical Therapy (NYSE:USPH) Aren't Ideal

Jan 03

Shareholders Should Be Pleased With U.S. Physical Therapy, Inc.'s (NYSE:USPH) Price

Nov 09

Recent updates

Capital Allocation Trends At U.S. Physical Therapy (NYSE:USPH) Aren't Ideal

Jan 03

Shareholders Should Be Pleased With U.S. Physical Therapy, Inc.'s (NYSE:USPH) Price

Nov 09

U.S. Physical Therapy (NYSE:USPH) Might Be Having Difficulty Using Its Capital Effectively

Aug 07

U.S. Physical Therapy (NYSE:USPH) Has A Rock Solid Balance Sheet

Jul 17

U.S. Physical Therapy, Inc.'s (NYSE:USPH) Business Is Trailing The Industry But Its Shares Aren't

Jun 04

There May Be Reason For Hope In U.S. Physical Therapy's (NYSE:USPH) Disappointing Earnings

May 21

U.S. Physical Therapy (NYSE:USPH) Is Due To Pay A Dividend Of $0.44

May 11

Returns On Capital Signal Tricky Times Ahead For U.S. Physical Therapy (NYSE:USPH)

May 05

A Look At The Fair Value Of U.S. Physical Therapy, Inc. (NYSE:USPH)

Apr 21

Is Now The Time To Look At Buying U.S. Physical Therapy, Inc. (NYSE:USPH)?

Apr 07

U.S. Physical Therapy, Inc.'s (NYSE:USPH) Shareholders Might Be Looking For Exit

Mar 04

The Returns On Capital At U.S. Physical Therapy (NYSE:USPH) Don't Inspire Confidence

Dec 23

Why U.S. Physical Therapy, Inc. (NYSE:USPH) Could Be Worth Watching

Dec 07

U.S. Physical Therapy: Positioned For Market Dominance Amidst Attractive Valuations

Oct 13

Are U.S. Physical Therapy, Inc. (NYSE:USPH) Investors Paying Above The Intrinsic Value?

Aug 01

U.S. Physical Therapy: Bolt-On Strategy Scaling Earnings Power (Rating Upgrade)

Jul 19

At US$114, Is U.S. Physical Therapy, Inc. (NYSE:USPH) Worth Looking At Closely?

May 07

U.S. Physical Therapy, Inc.'s (NYSE:USPH) Intrinsic Value Is Potentially 25% Below Its Share Price

Apr 16

U.S. Physical Therapy (NYSE:USPH) Has A Pretty Healthy Balance Sheet

Apr 01

Some Investors May Be Worried About U.S. Physical Therapy's (NYSE:USPH) Returns On Capital

Mar 04

U.S. Physical Therapy beats Q4 top and bottom line estimates; initiates FY23 outlook

Feb 23

U.S. Physical Therapy: Needs To Illustrate Economic Reality Over Accounting Profit

Feb 12

Is Now An Opportune Moment To Examine U.S. Physical Therapy, Inc. (NYSE:USPH)?

Jan 24

We Think U.S. Physical Therapy (NYSE:USPH) Can Stay On Top Of Its Debt

Dec 20

Here's Why We Think U.S. Physical Therapy (NYSE:USPH) Is Well Worth Watching

Dec 05

U.S. Physical Therapy: Not The Most Comfortable Prospect

Nov 09

Shareholder Returns

	USPH	US Healthcare	US Market
7D	-3.0%	0.7%	-0.2%
1Y	-5.0%	-10.7%	25.8%

Return vs Industry: USPH exceeded the US Healthcare industry which returned -10.6% over the past year.

Return vs Market: USPH underperformed the US Market which returned 25.6% over the past year.

Price Volatility

Is USPH's price volatile compared to industry and market?
USPH volatility
USPH Average Weekly Movement	6.1%
Healthcare Industry Average Movement	7.6%
Market Average Movement	6.4%
10% most volatile stocks in US Market	18.6%
10% least volatile stocks in US Market	3.1%

Stable Share Price: USPH has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: USPH's weekly volatility (6%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1990	5,310	Chris Reading	www.usph.com

U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

U.S. Physical Therapy, Inc. Fundamentals Summary

How do U.S. Physical Therapy's earnings and revenue compare to its market cap?
USPH fundamental statistics
Market cap	US$1.33b
Earnings (TTM)	US$14.10m
Revenue (TTM)	US$639.06m

94.4x

P/E Ratio

2.1x

P/S Ratio

Is USPH overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
USPH income statement (TTM)
Revenue	US$639.06m
Cost of Revenue	US$513.20m
Gross Profit	US$125.86m
Other Expenses	US$111.76m
Earnings	US$14.10m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	0.93
Gross Margin	19.69%
Net Profit Margin	2.21%
Debt/Equity Ratio	21.2%

How did USPH perform over the long term?

See historical performance and comparison

Dividends

2.0%

Current Dividend Yield

187%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/05 06:02
End of Day Share Price	2025/01/03 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

U.S. Physical Therapy, Inc. is covered by 16 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Michael Petusky	Barrington Research Associates, Inc.
Alexander Paris	Barrington Research Associates, Inc.
Joanna Sylvia Gajuk	BofA Global Research

USPH Stock Overview

Rewards

Risk Analysis

Injury Prevention Expansion And Acquisitions Will Drive Future Performance

U.S. Physical Therapy, Inc. Competitors

NYSEAM:NHC

US$1.6b

NYSE:PACS

US$2.1b

NYSE:ARDT

US$2.4b

NYSE:SEM

US$2.4b

Price History & Performance

Recent News & Updates

Capital Allocation Trends At U.S. Physical Therapy (NYSE:USPH) Aren't Ideal

New minor risk - Insider selling

President & COO recently sold US$192k worth of stock

Shareholders Should Be Pleased With U.S. Physical Therapy, Inc.'s (NYSE:USPH) Price

Upcoming dividend of US$0.44 per share

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on December 6, 2024

Recent updates

Capital Allocation Trends At U.S. Physical Therapy (NYSE:USPH) Aren't Ideal

New minor risk - Insider selling

President & COO recently sold US$192k worth of stock

Shareholders Should Be Pleased With U.S. Physical Therapy, Inc.'s (NYSE:USPH) Price

Upcoming dividend of US$0.44 per share

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on December 6, 2024

U.S. Physical Therapy, Inc. to Report Q3, 2024 Results on Nov 05, 2024

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on September 13, 2024

U.S. Physical Therapy, Inc. announced delayed 10-Q filing

U.S. Physical Therapy (NYSE:USPH) Might Be Having Difficulty Using Its Capital Effectively

U.S. Physical Therapy, Inc. to Report Q2, 2024 Results on Aug 13, 2024

U.S. Physical Therapy (NYSE:USPH) Has A Rock Solid Balance Sheet

Now 20% undervalued after recent price drop

U.S. Physical Therapy, Inc.'s (NYSE:USPH) Business Is Trailing The Industry But Its Shares Aren't

Chairman & CEO notifies of intention to sell stock

Chairman & CEO recently sold US$212k worth of stock

There May Be Reason For Hope In U.S. Physical Therapy's (NYSE:USPH) Disappointing Earnings

Chief Operating Officer - East recently sold US$261k worth of stock

U.S. Physical Therapy (NYSE:USPH) Is Due To Pay A Dividend Of $0.44

First quarter dividend of US$0.44 announced

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Returns On Capital Signal Tricky Times Ahead For U.S. Physical Therapy (NYSE:USPH)

A Look At The Fair Value Of U.S. Physical Therapy, Inc. (NYSE:USPH)

U.S. Physical Therapy, Inc., Annual General Meeting, May 21, 2024

Is Now The Time To Look At Buying U.S. Physical Therapy, Inc. (NYSE:USPH)?

Executive VP recently sold US$213k worth of stock

Executive VP notifies of intention to sell stock

Price target increased by 9.0% to US$119

Chief Operating Officer - West recently sold US$274k worth of stock

U.S. Physical Therapy, Inc.'s (NYSE:USPH) Shareholders Might Be Looking For Exit

Upcoming dividend of US$0.44 per share

Fourth quarter dividend increased to US$0.44

New minor risk - Profit margin trend

Full year 2023 earnings: EPS misses analyst expectations

U.S. Physical Therapy, Inc. Increases Quarterly Dividend, Payable on April 5, 2024

U.S. Physical Therapy, Inc. to Report Q4, 2023 Results on Feb 28, 2024

U.S. Physical Therapy, Inc. to Report Q4, 2023 Results on Feb 28, 2024

The Returns On Capital At U.S. Physical Therapy (NYSE:USPH) Don't Inspire Confidence

Why U.S. Physical Therapy, Inc. (NYSE:USPH) Could Be Worth Watching

Now 20% undervalued after recent price drop

Price target decreased by 9.6% to US$110

Consensus EPS estimates fall by 10%

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on December 8, 2023

Price target decreased by 7.9% to US$118

Now 20% undervalued after recent price drop

U.S. Physical Therapy, Inc. to Report Q3, 2023 Results on Nov 07, 2023

U.S. Physical Therapy: Positioned For Market Dominance Amidst Attractive Valuations

Is U.S. Physical Therapy (NYSE:USPH) A Risky Investment?

U.S. Physical Therapy (NYSE:USPH) Could Be Struggling To Allocate Capital

Chief Operating Officer - West recently sold US$452k worth of stock

Should You Think About Buying U.S. Physical Therapy, Inc. (NYSE:USPH) Now?

Chief Operating Officer - West notifies of intention to sell stock

Second quarter 2023 earnings: EPS misses analyst expectations

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on September 8, 2023

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired a 70% stake in U.S. Physical Therapy, Inc. (NYSE:USPH) for $2.1 million.

Are U.S. Physical Therapy, Inc. (NYSE:USPH) Investors Paying Above The Intrinsic Value?

U.S. Physical Therapy, Inc. to Report Q2, 2023 Results on Aug 08, 2023

U.S. Physical Therapy: Bolt-On Strategy Scaling Earnings Power (Rating Upgrade)